Crinetics Pharmaceuticals (CRNX) Other Non-Current Assets (2017 - 2026)

Crinetics Pharmaceuticals' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $800000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 38.46% year-over-year to $800000.0; the TTM figure through Mar 2026 stood at $800000.0 (down 38.46% YoY), while the FY2025 annual figure was $22.3 million, up 689.22% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $800000.0, down from $22.3 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $22.3 million in Q4 2025, with the low at $500000.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $1.3 million (2022), against an average of $2.6 million.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets surged 689.22% in 2025, then sank 38.46% in 2026.
• Crinetics Pharmaceuticals' Other Non-Current Assets stood at $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then soared by 117.62% to $2.8 million in 2024, then soared by 689.22% to $22.3 million in 2025, then tumbled by 96.42% to $800000.0 in 2026.
• Business Quant data shows CRNX's Other Non-Current Assets at $800000.0 in Q1 2026, $22.3 million in Q4 2025, and $1.3 million in Q3 2025.